Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Singapore Resorts To Preventive Care To Cut Healthcare Costs

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Precision Diagnostics Accelerating Early Detection

The fundamental strategy of clinical medicine is shifting from managing symptoms to identifying the earliest molecular indicators of disease. By integrating sophisticated genomic analysis with high-fidelity imaging, practitioners are now able to intercept pathological processes long before they manifest as systemic illness, significantly improving the efficacy of therapeutic interventions.

UK Medical Device Testing Jumps 17%,...

Clinical investigations of medical devices in the UK reached...

According to a report from GlobalData, Singapore’s intentions to implement a new healthcare reform called “Healthier SG” that aims to change the country’s healthcare approach from reactionary to preventative medicine will provide a resolution to rising healthcare expenditures in the city-state.

In order to address chronic diseases, Singapore wants to offer a family doctor, a health plan, and reasonably priced medications first to the population 60 years of age and older, and then progressively to those in other age categories.

As per GlobalData, the programme will assist people in comprehending their current state of health, identifying their medical requirements and health objectives, and developing an action plan that may include making lifestyle changes, managing their weight, scheduling screenings, or receiving vaccinations. People will have enough freedom to select and switch doctors as necessary.

The research also stated that Singapore provides an excellent basis for firms to establish new models of operation centered on big data and patient-centric care.

The action emphasises how crucial it is for people to take charge of their health, according to the report. According to a survey, the Singaporean market for medical devices is predicted to grow to $3.5 billion by 2022. Singapore is currently home to more than 60 international MedTech businesses, with operations spanning from regional headquarters and manufacturing to development and research.

The two main causes that may have impacted Singapore’s choice to introduce the new healthcare legislation plan are an ageing population and a rising burden of long-term diseases like obesity and hypertension, as per medical devices analyst at GlobalData, Pratibha Thammanabhatla.

As the population ages and requires more medical care, the plan will help the nation’s healthcare system, according to Thammanabhatla.

According to her, Singapore has always placed a high premium on health and is dedicated to modernising its healthcare system by remaining open to ideas and collaborations, embracing new technologies, and launching new government initiatives.

When it comes to displaying government initiatives and policies that, if properly developed and followed, may make a significant difference in people’s lives, the country always sets a precedent for other nations, she added.

Latest stories

Related stories

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Precision Diagnostics Accelerating Early Detection

The fundamental strategy of clinical medicine is shifting from managing symptoms to identifying the earliest molecular indicators of disease. By integrating sophisticated genomic analysis with high-fidelity imaging, practitioners are now able to intercept pathological processes long before they manifest as systemic illness, significantly improving the efficacy of therapeutic interventions.

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse Bone Graft in TLIF

Medtronic announced that it has secured FDA premarket approval...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »